staceywhite, Author at European Medical Journal - Page 33 of 195

Managing Respiratory Diseases

The Impact of Gestational Diabetes on Long-Term Kidney Disease

Gestational diabetes mellitus (GDM) is a pervasive metabolic disorder associated with a spectrum of long-term adverse outcomes. Recent…

The latest issue of EMJ Diabetes

The latest edition of EMJ Diabetes is out now, featuring key insights from EASD 2024. Discover the impact of circadian meal timing on…

Consequences of Disintegrated Care for Dual Tuberculosis and Diabetes

Diabetes is known to be a risk factor for active pulmonary tuberculosis (TB) and the reactivation of latent or previous TB. It is also…

Advances in proteinuria-targeting therapy in IgAN

Advances in Therapy to Address Proteinuria in Patients with Immunoglobulin A Nephropathy. As the majority of patients with IgA…

The Androgen Deprivation Therapy Landscape in 2024 – Co-navigating the Available Options with Prostate Cancer Patients

This industry symposium took place on 5th April 2024 during the 39th Annual European Association of Urology (EAU) Congress in Paris, France…

Don’t Hold Your Breath: Adapt and Become More Resilient Against Air Pollution

This infographic covers a symposium at ERS where impact of air pollution in respiratory health was discussed. This can lead to conditions…

Antifibrotic Treatment Efficacy in Progressive Pulmonary Fibrosis

In cases of pulmonary fibrosis attributable to interstitial lung disease, whether the aetiology is known or unknown, the presence…

Understanding COPD: Current Treatments and Emerging Breakthroughs

Exploring Chronic obstructive pulmonary disease (COPD), this infographic highlights the global incidence, current management strategies…

Phase IIb Study Design of Inhaled Pirfenidone for Progressive Pulmonary Fibrosis Treatment

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of pulmonary…